D.E. Shaw & Co’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.6M Buy
49,935
+4,816
+11% +$2.42M 0.01% 1044
2025
Q4
$21.1M Buy
45,119
+43,439
+2,586% +$20.2M 0.01% 1220
2025
Q3
$716K Sell
1,680
-5,511
-77% -$2.14M ﹤0.01% 3666
2025
Q2
$2.75M Sell
7,191
-31,123
-81% -$11.2M ﹤0.01% 2498
2025
Q1
$13.2M Sell
38,314
-16,151
-30% -$5.19M 0.01% 1196
2024
Q4
$16.3M Buy
54,465
+22,883
+72% +$8M 0.01% 1163
2024
Q3
$12.8M Buy
31,582
+4,123
+15% +$1.51M 0.01% 1257
2024
Q2
$8.82M Sell
27,459
-37,633
-58% -$12.2M 0.01% 1411
2024
Q1
$21.7M Sell
65,092
-110
-0.2% -$33.6K 0.02% 883
2023
Q4
$17.6M Buy
65,202
+45,902
+238% +$11.3M 0.02% 1013
2023
Q3
$4.75M Sell
19,300
-75,549
-80% -$20.7M 0.01% 1849
2023
Q2
$28.8M Sell
94,849
-9,678
-9% -$2.69M 0.03% 674
2023
Q1
$27.6M Buy
104,527
+39,125
+60% +$9.94M 0.03% 706
2022
Q4
$15.7M Sell
65,402
-129,345
-66% -$29M 0.02% 1080
2022
Q3
$35.8M Sell
194,747
-217,780
-53% -$43.4M 0.04% 537
2022
Q2
$69.3M Buy
412,527
+257,483
+166% +$55.3M 0.08% 280
2022
Q1
$38.9M Buy
155,044
+133,347
+615% +$33.5M 0.04% 610
2021
Q4
$5.57M Sell
21,697
-72,950
-77% -$17.9M ﹤0.01% 2254
2021
Q3
$23M Buy
94,647
+91,012
+2,504% +$22.3M 0.02% 935
2021
Q2
$751K Buy
+3,635
New +$741K ﹤0.01% 3772
2021
Q1
Sell
-1,924
Closed -$339K 4230
2020
Q4
$316K Sell
1,924
-18,995
-91% -$2.78M ﹤0.01% 3586
2020
Q3
$2.61M Sell
20,919
-357,697
-94% -$44.3M ﹤0.01% 2192
2020
Q2
$36.7M Buy
378,616
+373,155
+6,833% +$38.8M 0.04% 487
2020
Q1
$491K Sell
5,461
-776
-12% -$100K ﹤0.01% 3220
2019
Q4
$922K Sell
6,237
-40,546
-87% -$5.44M ﹤0.01% 3050
2019
Q3
$5.63M Sell
46,783
-24,369
-34% -$3.15M 0.01% 1562
2019
Q2
$9.62M Sell
71,152
-186,747
-72% -$23.6M 0.01% 1154
2019
Q1
$33.6M Buy
257,899
+15,846
+7% +$2.13M 0.04% 505
2018
Q4
$30.1M Buy
242,053
+149,904
+163% +$20.1M 0.04% 518
2018
Q3
$12.8M Sell
92,149
-104,644
-53% -$13M 0.02% 979
2018
Q2
$20.2M Buy
196,793
+92,527
+89% +$9.36M 0.03% 718
2018
Q1
$10.1M Sell
104,266
-57,105
-35% -$5.54M 0.01% 991
2017
Q4
$14.2M Sell
161,371
-243,551
-60% -$19.6M 0.02% 834
2017
Q3
$32.2M Buy
404,922
+182,257
+82% +$14.7M 0.05% 447
2017
Q2
$19.4M Buy
222,665
+57,268
+35% +$4.84M 0.03% 598
2017
Q1
$14.7M Sell
165,397
-8,517
-5% -$710K 0.03% 719
2016
Q4
$12.9M Sell
173,914
-873,889
-83% -$65.4M 0.02% 823
2016
Q3
$79.2M Buy
1,047,803
+523,791
+100% +$40.1M 0.14% 163
2016
Q2
$40.4M Buy
524,012
+442,267
+541% +$34.9M 0.07% 314
2016
Q1
$6.38M Sell
81,745
-1,614,852
-95% -$113M 0.01% 1118
2015
Q4
$115M Sell
1,696,597
-1,339,671
-44% -$93.4M 0.17% 139
2015
Q3
$235M Buy
3,036,268
+2,047,141
+207% +$181M 0.35% 48
2015
Q2
$89.7M Buy
989,127
+629,199
+175% +$50.4M 0.13% 165
2015
Q1
$27.1M Sell
359,928
-1,708,167
-83% -$123M 0.04% 503
2014
Q4
$152M Sell
2,068,095
-849,096
-29% -$59.7M 0.2% 92
2014
Q3
$206M Buy
2,917,191
+484,963
+20% +$32.1M 0.27% 61
2014
Q2
$137M Buy
2,432,228
+24,258
+1% +$1.28M 0.19% 101
2014
Q1
$126M Buy
2,407,970
+1,381,323
+135% +$68.7M 0.18% 106
2013
Q4
$49M Sell
1,026,647
-879,076
-46% -$40.6M 0.07% 323
2013
Q3
$81.5M Sell
1,905,723
-516,215
-21% -$20.2M 0.13% 166
2013
Q2
$87.3M Buy
+2,421,938
New +$93.7M 0.16% 124

Other funds holding HCA

D.E. Shaw & Co's HCA Position: Q1 2026 in Review

D.E. Shaw & Co increased its HCA Healthcare (HCA) stake by 11% in Q1 2026, buying an estimated $2.42M and bringing the position to 49,935 shares worth $23.6M. The position accounts for 0.01% of the portfolio, ranked #1044.

D.E. Shaw & Co first reported a position in HCA in Q2 2013 and has held it in 51 quarters since. The position peaked at $235M in Q3 2015. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • D.E. Shaw & Co held 49,935 shares of HCA Healthcare worth $23.6M as of Q1 2026.
  • D.E. Shaw & Co bought 4,816 HCA Healthcare shares in Q1 2026, an estimated $2.42M.
  • HCA Healthcare made up 0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #1044 holding.
  • D.E. Shaw & Co first reported a position in HCA Healthcare in Q2 2013 and has held it in 51 quarters since.
  • D.E. Shaw & Co's HCA Healthcare position peaked at $235M in Q3 2015.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.